Floatz logo

67 assets in B-Cell Chronic Lymphocytic Leukemia

Therapeutic assets addressing B-Cell Chronic Lymphocytic Leukemia, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Acalabrutinib
B-Cell Chronic Lymphocytic Leukemia
Zulfa OmerP4BBB (75)
Fludarabine
B-Cell Chronic Lymphocytic Leukemia
Ohio State University Comprehensive Cancer CenterP4BBB (75)
Rituximab
B-Cell Chronic Lymphocytic Leukemia
Zulfa OmerP4BBB (73)
Cyclophosphamide
B-Cell Chronic Lymphocytic Leukemia
Ohio State University Comprehensive Cancer CenterP4BBB (72)
Cediranib
B-Cell Chronic Lymphocytic Leukemia
City of Hope Medical CenterP2BB (71)
Obinutuzumab
B-Cell Chronic Lymphocytic Leukemia
Paolo Caimi, MDP3BB (71)
Bendamustine
B-Cell Chronic Lymphocytic Leukemia
Mayo ClinicP3BB (70)
Ibrutinib
B-Cell Chronic Lymphocytic Leukemia
Janssen Research & Development, LLCP4BB (70)
Chlorambucil
B-Cell Chronic Lymphocytic Leukemia
Janssen Research & Development, LLCP3BB (69)
Lenalidomide
B-Cell Chronic Lymphocytic Leukemia
Vitebsk Regional Clinical Cancer CentreP3BB (69)
C-Car066
B-Cell Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)P2BB (67)
Etoposide
B-Cell Chronic Lymphocytic Leukemia
City of Hope Medical CenterP2BB (67)
Melphalan
B-Cell Chronic Lymphocytic Leukemia
H. Lee Moffitt Cancer Center and Research InstituteP2BB (66)
Pirtobrutinib
B-Cell Chronic Lymphocytic Leukemia
Newave Pharmaceutical IncP3BB (66)
Venetoclax
B-Cell Chronic Lymphocytic Leukemia
Zulfa OmerP3BB (66)
Azacitidine
B-Cell Chronic Lymphocytic Leukemia
Gustave Roussy, Cancer Campus, Grand ParisP3BB (65)
Nemtabrutinib
B-Cell Chronic Lymphocytic Leukemia
Merck Sharp & Dohme LLCP3BB (64)
Sirolimus
B-Cell Chronic Lymphocytic Leukemia
Masonic Cancer Center, University of MinnesotaP3BB (64)
Vincristine Sulfate
B-Cell Chronic Lymphocytic Leukemia
Fred Hutchinson Cancer CenterP2BB (64)
Nivolumab
B-Cell Chronic Lymphocytic Leukemia
M.D. Anderson Cancer CenterP2B (62)
Jcar-017 Cd19-Specific Chimeric Antigen Receptor
B-Cell Chronic Lymphocytic Leukemia
Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyP3B (61)
Rocbrutinib
B-Cell Chronic Lymphocytic Leukemia
Newave Pharmaceutical IncP3B (60)
Xembify
B-Cell Chronic Lymphocytic Leukemia
Grifols Therapeutics LLCP3B (60)
Idelalisib
B-Cell Chronic Lymphocytic Leukemia
Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyP3CCC (55)
Allopurinol
B-Cell Chronic Lymphocytic Leukemia
Masonic Cancer Center, University of MinnesotaP2CCC (53)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit
B-Cell Chronic Lymphocytic Leukemia
University of LiegeP2CCC (53)
cd22 car-transduced t cells
B-Cell Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)P1CCC (53)
Ipilimumab
B-Cell Chronic Lymphocytic Leukemia
M.D. Anderson Cancer CenterP1/2CCC (53)
Sonrotoclax
B-Cell Chronic Lymphocytic Leukemia
Fred Hutchinson Cancer CenterP2CCC (53)
Zanubrutinib
B-Cell Chronic Lymphocytic Leukemia
Fred Hutchinson Cancer CenterP2CCC (53)
Adriamycin
B-Cell Chronic Lymphocytic Leukemia
AstraZenecaP1/2CCC (52)
Duvelisib
B-Cell Chronic Lymphocytic Leukemia
City of Hope Medical CenterP2CCC (51)
Mirdametinib
B-Cell Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)P2CCC (50)
Prednisone
B-Cell Chronic Lymphocytic Leukemia
AstraZenecaP1/2CCC (50)
Safimaltib
B-Cell Chronic Lymphocytic Leukemia
Janssen Research & Development, LLCP1CCC (48)
Ublituximab
B-Cell Chronic Lymphocytic Leukemia
Weill Medical College of Cornell UniversityP2CCC (48)
Surovatamig
B-Cell Chronic Lymphocytic Leukemia
AstraZenecaP1/2CC (47)
(+)-Vincristine
B-Cell Chronic Lymphocytic Leukemia
AstraZenecaP1/2CC (47)
Autologous Hucd19 Car T Cells
B-Cell Chronic Lymphocytic Leukemia
National Cancer Institute (NCI)P1/2CC (45)
Immunoglobulin G4, Anti-(Human Cd3 Antigen) (Recombinant Human Monoclonal Jnj-75348780 ?4-Chain), Disulfide With Recombinant Human Monoclonal Jnj-75348780 ? Chain, (229?126?),(232?129?)-Bis(Disulfide) With Immunoglobulin, Anti-(Human Sialic Acid-Binding Ig-Like Lectin 2) (Recombinant Human Single-Domain Vhh Fragment)
B-Cell Chronic Lymphocytic Leukemia
Janssen Research & Development, LLCP1CC (44)
Jnj-64264681
B-Cell Chronic Lymphocytic Leukemia
Janssen Research & Development, LLCP1CC (44)
0.75x10^6 cells/kg car20.19.22 cells
B-Cell Chronic Lymphocytic Leukemia
Medical College of WisconsinP1CC (43)
Baff Car-T
B-Cell Chronic Lymphocytic Leukemia
Paolo Caimi, MDP1CC (43)
Bgb-21447
B-Cell Chronic Lymphocytic Leukemia
BeOne MedicinesP1CC (43)
Ricolinostat
B-Cell Chronic Lymphocytic Leukemia
Dana-Farber Cancer InstituteP1CC (43)
Tocilizumab
B-Cell Chronic Lymphocytic Leukemia
Jonsson Comprehensive Cancer CenterP1CC (43)
Autologous Anti-Cd19 Car-Expressing T-Lymphocytes Ic19/1563
B-Cell Chronic Lymphocytic Leukemia
Mayo ClinicP1CC (41)
Autologous Baffr-Targeting Car T Cells
B-Cell Chronic Lymphocytic Leukemia
Mayo ClinicP1CC (41)
Autologous Cd19Car-Cd28-Cd3Zeta-Egfrt-Expressing Tn/Mem-Enriched T-Lymphocytes
B-Cell Chronic Lymphocytic Leukemia
City of Hope Medical CenterP1CC (41)
Autologous Cd4+ And Cd8+ T Cells, Enriched From Peripheral Blood Mononuclear Cells (Pbmcs) Transduced With A Nonreplicative Self-Inactivating (Sin) Lentiviral Vector Encoding A Chimeric Antigen Receptor (Car) Consisting Of The Human Cd19-Specific Scfv, An Lgg4 Hinge Region, Cd28 Transmembrane Domain, Cd137 (4-1Bb) Co-Stimulatory Domain And Cd3 Zeta Signalling Domain, Under The Control Of A Hybrid Elongation Factor 1 Alpha (Ef1.Alpha.) And Human T Cell Leukemia Virus Type 1(Htlv-1) Regulatory Element Promoter And Woodchuck Hepatitis Virus Post-Transcriptional Regulatory Element (Wpre). The Vector Genome Also Encodes A Truncated Human Epidermal Growth Factor Receptor (Egfrt) That Is Co-Expressed With The Car And Cleaved From It By The T2A Self-Cleaving Peptide. The Vector Genome Also Contains A Splice Donor, A Fragment Of Gag, A Rev Response Element (Rre), A Mutated Central Polypurine Tract (Cppt), And A Splice Acceptor
B-Cell Chronic Lymphocytic Leukemia
Shanghai Ming Ju Biotechnology Co., Ltd.P1CC (41)
Showing 1 to 50 of 67 assets
PreviousPage 1 of 2Next